Intellectual Property:  Dr. Le Poole and Dr. Nguyen are the inventors on the provisional patent on the therapeutic formulation. The company holds an option to license the IP as the patent gets awarded. In addition, Temprian Oncology works actively with the development of additional IP and trade secrets characteristic for oncology-oriented innovations.

The Market: The Total Available Market (TAM) for the Supercarriers addressing stage III and IV melanoma is estimated to be $1.5B in the United Sates. Considering the complex nature of cancer therapies, we estimate 2/3 of the market to be within our reach, putting the Serviceable Available Market (SAM) at $1B.  While the efficacy of the drug in combination with the existing standards-of-care will ultimately determine the demand, we estimate the Serviceable Obtainable Market (SOM) to range between $100M and $300M.  The international market is measured in billions of dollars.

Investors: Please contact Kettil Cedercreutz, (513)374-1180

General Inquiries: Temprian Oncology is hosted at Chicago’s premier Health Care Incubator MATTER located in down town Chicago.

Temprian Oncology, Inc 222 W Merchandise Mart Plaza Suite 1230
Chicago, Illinois, IL
(513) 374 1180